CORRESP Filing
NextCure, Inc.
Date: July 28, 2025 · CIK: 0001661059 · Accession: 0001104659-25-071121
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288763
Letter
9000 Virginia Manor Road, Suite 200
Beltsville, Maryland 20705
Tel : (240) 399-4900
July 28, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Tim Buchmiller
Re: NextCure, Inc.
Registration Statement on Form S-3
File No. 333-288763
Acceleration Request
Requested Date: July 29, 2025
Requested Time: 4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, NextCure, Inc. (the " Company ") hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (the " Registration Statement "), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on July 29, 2025, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
Please contact Kostian Ciko of Sidley Austin LLP at (212) 839-5450 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
/s/ Michael Richman
Show Raw Text
CORRESP 1 filename1.htm 9000 Virginia Manor Road, Suite 200 Beltsville, Maryland 20705 Tel : (240) 399-4900 July 28, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Tim Buchmiller Re: NextCure, Inc. Registration Statement on Form S-3 File No. 333-288763 Acceleration Request Requested Date: July 29, 2025 Requested Time: 4:00 P.M., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, NextCure, Inc. (the " Company ") hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (the " Registration Statement "), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on July 29, 2025, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Please contact Kostian Ciko of Sidley Austin LLP at (212) 839-5450 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement. Very truly yours, /s/ Michael Richman Michael Richman Chief Executive Officer NextCure, Inc. cc: Steven Cobourn, NextCure, Inc. Asher Rubin, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP